RLS Global, and ConvaTec have made continued progress with the distribution and commercialisation of ChloraSolv® in Europe. After intensive market preparation and work with specialist wound experts in the Netherlands, ChloraSolv® gel was listed on January 1, 2022 in the Z- index and received a positive recommendation for reimbursement from Zorginstituut Nederland (ZN). Chlorasolv® is already available in other European markets such as the Nordic countries.
1st Jan change | Capi. | |
---|---|---|
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |